Zydus Lifesciences informs about press release

07 Mar 2022 Evaluate

Zydus Lifesciences has informed that it enclosed a copy of press release dated March 7, 2022 titled ‘Zydus to launch Oxemia (Desidustat) a breakthrough treatment for Anemia in patients suffering from Chronic Kidney Disease (CKD)’.

The above information is a part of company’s filings submitted to BSE.



Zydus Lifesciences Share Price

885.00 8.90 (1.02%)
22-Jan-2026 11:03 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.95
Dr. Reddys Lab 1219.55
Cipla 1373.95
Zydus Lifesciences 885.00
Lupin 2175.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×